Effects of chronic treatment with levetiracetam on hippocampal field responses after pilocarpine-induced status epilepticus in rats

Brain Research Bulletin

Volumn 77, Issue 5, 2008, Pages 282-285

  Margineanu, Doru Georg ^a   Matagne, Alain ^a   Kaminski, Rafal M ^a   Klitgaard, Henrik ^a  

^a UCB PHARMA   (Belgium)

Author keywords

Antiepileptic drugs; Epilepsy; Epileptogenesis; Levetiracetam; Pilocarpine; Rat; SV2A

Indexed keywords

DIAZEPAM; ETIRACETAM; PILOCARPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFECT; EPILEPTIC STATE; EXPERIMENTAL MODEL; HIPPOCAMPUS; MALE; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; SYNAPSE VESICLE;

ANIMALS; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; HUMANS; MALE; MEMBRANE POTENTIALS; MUSCARINIC AGONISTS; PILOCARPINE; PIRACETAM; RATS; RATS, SPRAGUE-DAWLEY; STATUS EPILEPTICUS;

EID: 54549114411     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2008.07.006     Document Type: Article

References (25)

1. Brandt C., Glien M., Gastens A.M., Fedrowitz M., Bethmann K., Volk H.A., Potschka H., and Loscher W. Prophylactic treatment with levetiracetam after status epilepticus: lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats. Neuropharmacology 53 (2007) 207-221
2. Cavalheiro E.A., Leite J.P., Bortolotto Z.A., Turski W.A., Ikonomidou C., and Turski L. Long-term effects of pilocarpine in rats: structural damage of the brain triggers kindling and spontaneous recurrent seizures. Epilepsia 32 (1991) 778-782
3. Dudek F.E., Bertram E.H., and Staley K.J. Antiepileptogenesis Therapy with Levetiracetam: data from kindling versus status epilepticus models. Epilepsy Curr. 8 (2008) 28-30
4. Glien M., Brandt C., Potschka H., and Loscher W. Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy. Epilepsia 43 (2002) 350-357
5. Husum H., Bolwig T.G., Sanchez C., Mathe A.A., and Hansen S.L. Levetiracetam prevents changes in levels of brain-derived neurotrophic factor and neuropeptide Y mRNA and of Y1- and Y5-like receptors in the hippocampus of rats undergoing amygdala kindling: implications for antiepileptogenic and mood-stabilizing properties. Epilepsy Behav. 5 (2004) 204-215
6. Ji-Qun C., Ishihara K., Nagayama T., Serikawa T., and Sasa M. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs. Epilepsia 46 (2005) 1362-1370
7. Klitgaard H., Matagne A., Gobert J., and Wulfert E. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. Eur. J. Pharmacol. 353 (1998) 191-206
8. Klitgaard H., Matagne A., Grimee R., Vanneste-Goemaere J., and Margineanu D.G. Electrophysiological, neurochemical and regional effects of levetiracetam in the rat pilocarpine model of temporal lobe epilepsy. Seizure 12 (2003) 92-100
9. Klitgaard H., Matagne A., Vanneste-Goemaere J., and Margineanu D.G. Pilocarpine-induced epileptogenesis in the rat: impact of initial duration of status epilepticus on electrophysiological and neuropathological alterations. Epilepsy Res. 51 (2002) 93-107
10. Klitgaard H., and Pitkanen A. Antiepileptogenesis, neuroprotection, and disease modification in the treatment of epilepsy: focus on levetiracetam. Epileptic Disord. 5 Suppl. 1 (2003) S9-16
11. Lasztoczi B., Emri Z., Szarics E., Heja L., Simon A., Nyikos L., and Kardos J. Suppression of neuronal network excitability and seizure-like events by 2-methyl-4-oxo-3H-quinazoline-3-acetyl piperidine in juvenile rat hippocampus: involvement of a metabotropic glutamate receptor. Neurochem. Int. 49 (2006) 41-54
12. Leite J.P., Garcia-Cairasco N., and Cavalheiro E.A. New insights from the use of pilocarpine and kainate models. Epilepsy Res. 50 (2002) 93-103
13. Loscher W. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res. 50 (2002) 105-123
14. Löscher W., and Honack D. Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats. Eur. J. Pharmacol. 232 (1993) 147-158
15. Loscher W., Honack D., and Rundfeldt C. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy. J. Pharmacol. Exp. Ther. 284 (1998) 474-479
16. Lynch B.A., Lambeng N., Nocka K., Kensel-Hammes P., Bajjalieh S.M., Matagne A., and Fuks B. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 9861-9866
17. Ma D.L., Chia S.C., Tang Y.C., Chang M.L., Probst A., Burgunder J.M., and Tang F.R. Spastin in the human and mouse central nervous system with special reference to its expression in the hippocampus of mouse pilocarpine model of status epilepticus and temporal lobe epilepsy. Neurochem. Int. 49 (2006) 651-664
18. Moulder K.L., Jiang X., Taylor A.A., Shin W., Gillis K.D., and Mennerick S. Vesicle pool heterogeneity at hippocampal glutamate and GABA synapses. J. Neurosci. 27 (2007) 9846-9854
19. Moulder K.L., Meeks J.P., and Mennerick S. Homeostatic regulation of glutamate release in response to depolarization. Mol. Neurobiol. 33 (2006) 133-153
20. Moulder K.L., and Mennerick S. Reluctant vesicles contribute to the total readily releasable pool in glutamatergic hippocampal neurons. J. Neurosci. 25 (2005) 3842-3850
21. Noyer M., Gillard M., Matagne A., Henichart J.P., and Wulfert E. The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes. Eur. J. Pharmacol. 286 (1995) 137-146
22. Patsalos P.N. Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacol. Ther. 85 (2000) 77-85
23. Rogawski M.A., and Loscher W. The neurobiology of antiepileptic drugs. Nat. Rev. Neurosci. 5 (2004) 553-564
24. Turski W.A., Cavalheiro E.A., Schwarz M., Czuczwar S.J., Kleinrok Z., and Turski L. Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study. Behav. Brain Res. 9 (1983) 315-335
25. Yang X.F., Weisenfeld A., and Rothman S.M. Prolonged exposure to levetiracetam reveals a presynaptic effect on neurotransmission. Epilepsia 48 (2007) 1861-1869